טוען...

The Impact of IDH1 Mutation and MGMT Promoter Methylation on Recurrence-Free Interval in Glioblastoma Patients Treated With Radiotherapy and Chemotherapeutic Agents

The aim of this study is to investigate the relationship between isocitrate dehydrogenase-1 (IDH1) mutation and O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation with recurrence-free interval in glioblastoma patients treated with chemoradiotherapies. Clinical data were collected f...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Pathol Oncol Res
Main Authors: Kurdi, Maher, Shafique Butt, Nadeem, Baeesa, Saleh, Alghamdi, Badrah, Maghrabi, Yazid, Bardeesi, Anas, Saeedi, Rothaina, Al-Sinani, Taghreed, Alghanmi, Najla, Bari, Mohammed O., Samkari, Alaa, Lary, Ahmed I.
פורמט: Artigo
שפה:Inglês
יצא לאור: Frontiers Media S.A. 2021
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC8262235/
https://ncbi.nlm.nih.gov/pubmed/34257620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/pore.2021.1609778
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!